Cataracts

1. Clinical Overview

Summary

A cataract is an opacification of the crystalline lens of the eye, leading to progressive visual impairment. It represents the leading cause of reversible blindness worldwide, accounting for approximately 51% of global blindness affecting an estimated 65.2 million people. [1,2] The vast majority are age-related ("senile cataracts"), resulting from cumulative oxidative damage to lens proteins (crystallins). [3,4]

Patients typically present with gradual, painless deterioration of vision over months to years, often describing symptoms of glare (starbursts around lights), difficulty with night driving, and impaired reading ability. The condition is progressive but entirely reversible through surgical intervention. Surgery is indicated when visual impairment affects the patient's quality of life, such as losing driving privileges or difficulty performing activities of daily living. [5]

Phacoemulsification with intraocular lens (IOL) implantation represents the gold standard surgical procedure and is the most frequently performed elective surgery in developed healthcare systems, with over 450,000 procedures performed annually in the UK NHS alone. [6] Success rates exceed 95%, with most patients achieving significant visual improvement and restoration of functional independence. [7]

Key Facts

Global Prevalence: Age-related cataract affects > 50% of individuals over 80 years, with prevalence increasing exponentially after age 60. [1]
Symptoms: Gradual painless loss of visual acuity, glare, monocular diplopia, color desaturation, myopic shift.
Red Reflex: Reduced or absent on direct ophthalmoscopy (dark shadows against red glow).
Steroid-Induced: Long-term systemic or topical corticosteroids cause posterior subcapsular cataracts, dose and duration-dependent. [8]
Surgical Success: 95-98% achieve visual improvement; most common complication is posterior capsule opacification (10-20%). [9]
Economic Impact: Cataract surgery represents one of the most cost-effective medical interventions globally.

Clinical Pearls

"Second Sight" Phenomenon: Some elderly patients suddenly discover they can read without their reading glasses after years of presbyopia. This is not presbyopia reversal but rather a myopic shift caused by nuclear sclerotic cataracts increasing the refractive index of the lens nucleus. Lens proteins become more densely packed and yellow/brown, creating increased minus power. This paradoxically improves near vision in hypermetropes but worsens distance vision.

"Glare vs Blur" Diagnostic Clue: Posterior subcapsular cataracts (PSC), common in diabetics and steroid users, cause disproportionate glare and photophobia compared to the degree of visual acuity reduction on Snellen testing. PSC opacities sit directly on the visual axis at the nodal point. When the pupil constricts in bright light or during reading (accommodation-miosis reflex), the opacity blocks the entire light pathway, causing severe symptoms despite "good" Snellen acuity in dim lighting.

"The Post-Operative Red Flag": A patient calling 2-5 days after cataract surgery complaining of increasing pain, redness, and deteriorating vision has acute endophthalmitis (intraocular infection) until proven otherwise. This is a true ocular emergency requiring immediate intravitreal antibiotic injection (vancomycin + ceftazidime) within hours to save sight. Incidence: ~1:1000-2000 cases. [10,11]

"Leukocoria Urgency": A white pupil (leukocoria) in a child is retinoblastoma until proven otherwise, not congenital cataract. Retinoblastoma is life-threatening. All cases require urgent ophthalmology assessment within 24-48 hours. Red reflex testing is a mandatory component of newborn examination (NIPE).

"Phacolytic Glaucoma": A hypermature cataract can cause acute secondary glaucoma through lens protein leakage into the anterior chamber, clogging the trabecular meshwork. Presents with painful red eye and raised intraocular pressure. Treatment: urgent cataract extraction, not medical glaucoma therapy alone.

2. Epidemiology

Global Burden

Cataract remains the leading cause of blindness worldwide despite being surgically curable. The Global Burden of Disease Study 2020 estimated that cataracts account for 15.2 million cases of blindness and 78.8 million cases of moderate-to-severe visual impairment globally. [2] Age-related cataract prevalence demonstrates marked geographic variation, with higher rates in low- and middle-income countries due to limited access to surgical services.

A comprehensive systematic review and meta-analysis by Hashemi et al. (2020) analyzing 58 population-based studies found the pooled global prevalence of age-related cataract to be 17.2% (95% CI: 12.6-23.1%). [1] Prevalence increases exponentially with age:

50-59 years: 3.9%
60-69 years: 19.0%
70-79 years: 42.8%
≥80 years: 68.3%

Risk Factors

Non-Modifiable Risk Factors

Age: Single most significant risk factor. Lens opacity begins in the fourth decade but becomes clinically significant in the seventh-eighth decades. [3,4]
Genetics:
- Heritability estimates: 35-58% for age-related cataract.
- Congenital cataracts: mutations in crystallin genes (CRYAA, CRYAB, CRYGC), connexins (GJA3, GJA8), aquaporin (MIP).
- Syndromes: Down syndrome (trisomy 21), Lowe syndrome (OCRL gene), myotonic dystrophy (DMPK gene).
Female Sex: Women have 1.2-1.5× higher risk, possibly related to estrogen effects and longer lifespan.
Ethnicity: Higher prevalence in Asian and Hispanic populations compared to Caucasians.

Modifiable Risk Factors

Ultraviolet Light Exposure: Cumulative UV-B radiation (290-320nm) causes oxidative damage to lens crystallins through photochemical reactions. [12] Sunlight exposure > 5 hours/day increases cortical cataract risk (OR 2.4). Protective effect of UV-blocking sunglasses demonstrated in epidemiological studies.
Diabetes Mellitus:
- Diabetics develop cataracts 10-15 years earlier than non-diabetics.
- Risk proportional to glycemic control (HbA1c).
- Mechanism: Aldose reductase converts excess glucose to sorbitol via polyol pathway. Sorbitol accumulates in lens (impermeable cell membranes), causing osmotic stress, water influx, and fiber swelling. [13]
- Synergistic effect: osmotic + oxidative stress. [14]
Corticosteroids:
- Dose and duration-dependent risk of posterior subcapsular cataracts.
- Systemic steroids: Risk increases with cumulative dose > 10mg prednisolone equivalent for > 1 year. [8]
- Topical steroids: Prolonged use (> 12 months) of potent preparations (dexamethasone, prednisolone acetate).
- Inhaled steroids: Moderate risk with high-dose long-term use.
- Mechanism: Glucocorticoids bind to lens epithelial cells, altering ion pump function and inducing oxidative stress.
Smoking:
- Current smokers: 2-3× increased risk (dose-dependent).
- Mechanism: Cadmium accumulation in lens, oxidative stress from free radicals.
- Smoking cessation reduces risk over time but may not return to baseline.
Alcohol: Heavy alcohol consumption (> 2 units/day) associated with modest increased risk.
Nutritional Deficiency:
- Low dietary antioxidants (vitamins C, E, carotenoids, lutein/zeaxanthin) associated with increased risk. [15]
- Malnutrition and protein-energy deficiency in developing countries.
Trauma:
- Penetrating injury: Direct lens capsule rupture causes rapid cataract formation.
- Blunt trauma: "Rosette cataract"

flower-petal pattern of posterior subcapsular opacity.
- Electric shock and lightning injury.
- Ionizing radiation exposure (nuclear, radiotherapy).

Medications:
- Anticholinesterases (dementia medications)
- Amiodarone (anterior subcapsular deposits)
- Statins (conflicting evidence - some studies suggest protective effect)

Congenital and Pediatric Cataracts

Incidence: 1-6 per 10,000 live births. Leading cause of treatable childhood blindness.
Etiology:
- Idiopathic: 50% of cases
- Genetic: 25% - autosomal dominant most common
- TORCH Infections:
  - Rubella (most common infectious cause) - "salt and pepper" retinopathy
  - CMV, Toxoplasmosis, Herpes simplex, Varicella
- Metabolic:
  - Galactosemia (GALT enzyme deficiency) - "oil droplet" cataract, reversible if early lactose-free diet
  - Galactokinase deficiency
  - Hypocalcemia (hypoparathyroidism)
- Systemic Syndromes: Down syndrome, Marfan syndrome, Lowe syndrome (oculocerebrorenal)

3. Pathophysiology

Anatomy of the Crystalline Lens

The human lens is a biconvex, avascular, transparent structure located behind the iris and suspended by zonular fibers from the ciliary body. Adult lens dimensions: approximately 9-10mm diameter, 4-5mm anteroposterior thickness (increases with age).

Structural Components:

Lens Capsule:
- Thick elastic basement membrane (5-20μm)
- Thickest at equator, thinnest at posterior pole
- Composed of type IV collagen and laminin
- Target of surgical continuous curvilinear capsulorhexis (CCC)
Lens Epithelium:
- Single layer of cuboidal cells on anterior surface only
- Germinative zone at equator produces new lens fibers throughout life
- Contains Na+/K+-ATPase pumps maintaining lens transparency
Lens Cortex:
- Younger, less compact lens fibers
- Higher water content (60-70%)
- Site of cortical cataract formation
Lens Nucleus:
- Central zone of oldest, compressed lens fibers
- Progressively hardens with age (lens sclerosis)
- Lower water content (~60%)
- Site of nuclear sclerotic cataract
Lens Fibers:
- Elongated, hexagonal cells
- Lose organelles during maturation (anucleate)
- Tightly packed with crystallin proteins (35% total lens weight)

Unique Metabolic Features:

Avascular: No blood vessels. Nutrients from aqueous humor via diffusion.
Low Oxygen Environment: less than 1% of corneal oxygen tension.
Anaerobic Glycolysis: Primary ATP generation pathway.
Continuous Growth: Lens increases mass throughout life (~2mg/year). Cannot shed cells, leading to progressive compaction of nucleus.

Molecular Pathophysiology of Cataract Formation

The lens maintains transparency through three critical factors: (1) crystallin protein organization, (2) absence of organelles in mature fibers, and (3) precise control of water and ion balance. Cataract formation disrupts these mechanisms. [3,4,16]

Oxidative Stress Theory

The oxidative stress hypothesis is the predominant mechanism for age-related cataract. [4,12]

Reactive Oxygen Species (ROS) Generation:
- UV radiation photolysis generates superoxide (O₂⁻), hydrogen peroxide (H₂O₂), hydroxyl radicals (·OH)
- Mitochondrial electron transport chain leakage (epithelial cells)
- Inflammation and aging processes
Crystallin Protein Damage: [3]
- Crystallins (α, β, γ families) constitute 90% of lens proteins
- ROS cause:
  - Oxidation of methionine and cysteine residues
  - Protein aggregation and high molecular weight complex formation
  - Cross-linking between crystallin molecules
  - Conformational changes disrupting short-range order
- Result: Loss of transparency through light scattering
Antioxidant Depletion: [12]
- Lens contains high glutathione (GSH) concentrations
- Age-related decline in GSH and antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase)
- Overwhelmed antioxidant defenses → cumulative oxidative damage
Post-Translational Modifications:
- Deamidation of asparagine and glutamine
- Glycation (non-enzymatic glucose attachment) forming advanced glycation end-products (AGEs)
- SUMOylation pathways implicated in age-related cataracts [17]

Osmotic Stress (Diabetic Cataracts)

In hyperglycemic conditions, the polyol (sorbitol) pathway becomes activated: [13,14]

Glucose → (Aldose Reductase) → Sorbitol → (Sorbitol Dehydrogenase) → Fructose

Sorbitol accumulates intracellularly (cell membranes impermeable)
Osmotic gradient → water influx → fiber swelling and rupture
NADPH depletion reduces glutathione regeneration → oxidative stress
Synergistic effect: osmotic + oxidative damage accelerates cataract formation [14]

Classification by Morphology

1. Nuclear Sclerotic Cataract

Most common type in age-related cataracts (> 60% of cases)
Pathology: Progressive compaction and yellowing/browning of lens nucleus
Mechanism:
- Oxidative damage to nuclear crystallins
- Protein aggregation and cross-linking
- Chromophore accumulation (yellow-brown pigments)
Clinical Features:
- Myopic shift: Increased refractive index of nucleus creates minus power (up to -1.5 to -3.0D shift). Hypermetropes may temporarily not need distance glasses; can read without reading glasses ("second sight").
- Brunescent (brown) or white (mature) nucleus on slit-lamp examination
- Hardness grading (Grade 1-4): affects surgical technique (harder nuclei require more phaco energy)
Visual Impact: Distance vision affected more than near vision

2. Cortical Cataract

Second most common age-related type (~25-30%)
Pathology: Wedge-shaped opacities in lens cortex, radiating from periphery toward center
Appearance: "Spoke-wheel" or "bike wheel" pattern on retroillumination
Mechanism:
- Hydration of cortical fibers
- Disruption of fiber architecture
- Water clefts between lamellae
Visual Impact:
- Glare from light scattering (especially with oblique illumination)
- Variable vision depending on pupil size and opacity location
- Better vision in dim light (dilated pupil allows peripheral rays)

3. Posterior Subcapsular Cataract (PSC)

Most visually debilitating relative to degree of opacity
Location: Granular plaque-like opacity at posterior lens capsule, directly on visual axis
Pathology: Migration and abnormal differentiation of lens epithelial cells posteriorly (Elschnig pearls)
Associations:
- Corticosteroids (most common iatrogenic cause) [8]
- Diabetes mellitus
- Radiation exposure
- Myopia (high myopes)
- Retinitis pigmentosa
- Chronic uveitis
Visual Impact:
- Disproportionate glare and photophobia
- Near vision severely affected: Miosis during accommodation/reading causes pupil to constrict over opacity
- Better distance vision in bright light (small pupil depth of focus effect)
- "Paradoxical" good Snellen acuity in dim light with dilated pupil

4. Specialty Cataracts

Christmas Tree Cataract: Polychromatic needle-like crystalline opacities. Associated with myotonic dystrophy (CTG repeat expansion in DMPK gene). Usually visually insignificant but pathognomonic finding.
Sunflower Cataract: Petal-shaped anterior capsular deposits. Pathognomonic of Wilson disease (copper deposition). Accompanies Kayser-Fleischer rings.
Blue Dot (Cerulean) Cataract: Small blue opacities in cortex. Autosomal dominant. Usually non-progressive and visually insignificant.
Rosette Cataract: Flower-petal pattern PSC. Classic finding after blunt ocular trauma or electrical injury.
Membranous Cataract: Complete lens resorption leaving only capsule. Result of untreated congenital cataract or trauma.

4. Clinical Presentation

Symptoms

Cataracts typically produce gradual, painless, progressive bilateral visual deterioration over months to years. Unilateral or asymmetric presentation is common due to differential risk factor exposure (trauma, steroid eye drops).

Core Visual Symptoms

Blurred Vision:
- Most common presenting complaint
- Patient descriptions: "misty," "foggy," "like looking through frosted glass," "dirty glasses that won't clean"
- Progressive worsening over time (distinguishes from acute retinal pathology)
- Initially correctable with refraction updates, eventually refractive correction ineffective
Glare and Photophobia:
- Light scattering from lens opacities
- Particular difficulty with oncoming headlights during night driving
- Haloes around streetlights and point light sources
- Sunlight intolerance requiring sunglasses
- PSC cataracts produce worst glare (central location on visual axis)
Impaired Contrast Sensitivity:
- Difficulty distinguishing objects in low contrast situations
- Problems with facial recognition
- Difficulty reading even with "adequate" Snellen acuity (explains patient dissatisfaction despite "good" VA)
Color Desaturation:
- Colors appear "washed out," faded, or yellowish
- Loss of color discrimination, especially blue spectrum
- Nuclear sclerotic cataracts cause yellow/brown tint to vision
- Patients often unaware until after surgery when colors appear "too bright"
Monocular Diplopia:
- Double vision in ONE eye (persists with other eye covered)
- Distinguishes from binocular diplopia (neurological/muscular causes)
- Mechanism: Split refraction through irregular lens opacities creating multiple images
- Usually resolves with pinhole testing
Frequent Prescription Changes:
- Myopic shift requiring more minus power (nuclear sclerotic)
- Astigmatic changes (cortical cataracts causing irregular lens surface)
- Inability to achieve satisfactory correction

Specific Presentations

Near Vision Improvement (Second Sight): Elderly hypermetropes may transiently improve near vision without reading glasses due to myopic shift. Often mistaken for presbyopia reversal.
Reduced Night Vision: Preferential difficulty in dim lighting suggests nuclear cataract. Paradoxically, PSC cataracts may have better night vision (dilated pupil allows peripheral vision around central opacity).
Unilateral Symptoms: Suggests asymmetric cataract formation. Investigate secondary causes (trauma, inflammation, steroid drops to one eye).

Clinical Examination

Visual Acuity Testing

Snellen Chart (or LogMAR):
- Reduced VA proportional to cataract density
- May maintain 6/9-6/12 with early cataracts
- Advanced cataracts: 6/60 to counting fingers
Pinhole Test:
- Modest improvement suggests refractive component
- Minimal improvement indicates media opacity (cataract) or retinal pathology
Testing Conditions:
- Test in bright and dim lighting
- PSC worse in bright light (pupil constriction)
- Nuclear sclerotic worse in dim light

Slit-Lamp Biomicroscopy

Gold standard for cataract diagnosis and classification.

Technique:
- Direct illumination: Opacity appears gray-white against dark background
- Retroillumination: Red reflex from retina; opacity appears as dark shadow
- Sclerotic scatter: Opacities appear bright against dark background
Grading Systems:
- LOCS III (Lens Opacities Classification System): Nuclear opalescence (NO), nuclear color (NC), cortical (C), PSC
- Clinical grading: Mild (1+), Moderate (2+), Severe (3+), Mature (4+)
- Nuclear hardness (surgical planning): Grade 1 (soft) to 4 (brunescent/rock hard)
Additional Findings:
- Phacodonesis: Wobble of lens with eye movement (zonular weakness - high surgical risk)
- Anterior chamber depth (shallow AC increases angle-closure risk during surgery)
- Pseudoexfoliation material (increased capsular rupture risk)

Ophthalmoscopy (Direct/Indirect)

Red Reflex Assessment:
- Normal: Bright, uniform red-orange glow
- Cataract: Reduced or absent red reflex; dark shadows/opacities against red background
- Pattern Recognition:
  - Central opacity → Nuclear or PSC
  - Peripheral spoke-wheel opacities → Cortical
  - Diffuse dullness → Dense/mature cataract
- Leukocoria (white pupil): Mature cataract, retinoblastoma (children), retinal detachment
Fundus Examination:
- View of retina progressively impaired as cataract density increases
- Critical: Assess for comorbid retinal pathology (diabetic retinopathy, AMD, retinal detachment) that will limit post-operative visual potential
- Dense cataracts prevent fundal view → require B-scan ultrasound to exclude retinal detachment

Ancillary Testing

Contrast Sensitivity Testing:
- Pelli-Robson or FACT charts
- More sensitive than Snellen for functional visual impairment
- Helps justify surgery in patients with "good" Snellen acuity but symptomatic glare
Glare Testing:
- Brightness Acuity Test (BAT): VA measured with bright light source
- Significant VA reduction with glare suggests PSC cataract
Potential Acuity Testing:
- Predicts post-operative visual outcome in presence of dense cataract
- Techniques: Laser interferometry, Potential Acuity Meter (PAM)
- Limited accuracy; cannot reliably rule out macular pathology
Ocular Biometry:
- Essential pre-operative test for IOL power calculation
- Optical biometry (IOLMaster, Lenstar): Non-contact, highly accurate
- Measures: Axial length (AL), keratometry (K), anterior chamber depth (ACD)
- Formulas: Barrett Universal II, SRK/T, Haigis, Hoffer Q, Holladay (selection based on axial length)
B-Scan Ultrasonography:
- Indicated when fundus view impossible due to dense cataract
- Excludes: Retinal detachment, vitreous hemorrhage, intraocular tumors, posterior staphyloma
- Crucial for surgical planning and patient counseling
Specular Microscopy:
- Assesses corneal endothelial cell count and morphology
- Normal: > 2000 cells/mm²
- Low endothelial count increases risk of corneal decompensation after surgery (contraindication if less than 1000 cells/mm²)

5. Management Algorithm

                    PATIENT WITH GRADUAL VISION LOSS
                               ↓
                     COMPREHENSIVE EYE EXAMINATION
                     (VA, Slit-Lamp, Fundoscopy)
                               ↓
                         CATARACT CONFIRMED
                               ↓
          ┌────────────────────┼───────────────────────┐
        MILD                MODERATE               SEVERE
    (VA 6/6-6/9,           (VA 6/12-6/18,         (VA less than 6/18,
  Minimal symptoms,      Symptomatic glare,      Significant
   Patient happy)        Driving affected)     functional impact)
          ↓                     ↓                      ↓
    CONSERVATIVE           SURGICAL              SURGICAL (URGENT)
     MANAGEMENT           CANDIDATE             
          ↓                     ↓                      ↓
  • Update refraction    • Patient counseling   • Pre-operative workup
  • UV-protective        • Informed consent     • Biometry (IOL calculation)
    sunglasses           • Pre-op assessment    • B-scan if dense cataract
  • Adequate lighting    • Biometry             • Medical optimization
  • Annual review        • Surgery booking      • Phacoemulsification + IOL
  • Advise re: symptoms  ↓                      
    progression      PHACOEMULSIFICATION        
                     + IOL IMPLANTATION         
                            ↓
                     POST-OPERATIVE CARE
                     • Day 1: Check for complications
                     • Week 1: Topical steroids/antibiotics
                     • Week 4-6: Refraction for glasses
                     • Monitor for PCO, CMO, RD

1. Conservative Management

Early cataracts causing minimal visual impairment do not require surgical intervention. Surgery is NOT indicated based solely on presence of lens opacity.

Non-Surgical Interventions

Refractive Optimization:
- Regular refraction to correct myopic shift
- Can temporarily restore functional vision
- Eventually becomes ineffective as opacity progresses
Environmental Modifications:
- UV-protective sunglasses: Reduce glare and may slow progression [12]
- Adequate lighting for reading and tasks
- Anti-glare coatings on spectacle lenses
- Large-print materials
Nutritional Supplementation:
- Observational studies suggest protective effect of antioxidants (vitamins C, E, carotenoids, lutein/zeaxanthin) [15]
- No high-quality RCT evidence supporting supplementation for established cataracts
- May have role in primary prevention
Medical Management of Risk Factors:
- Optimize diabetic control (HbA1c less than 7%)
- Minimize systemic corticosteroid use where possible
- Smoking cessation counseling
Regular Monitoring:
- Annual review for progression
- Re-assess when symptoms worsen
- Patient education: Return if driving difficulties, falls, reduced independence

No Pharmacological Treatment Exists: No eye drops or medications can reverse or significantly slow cataract progression. Beware of "cataract reversal" alternative medicine claims.

2. Surgical Management: Phacoemulsification

Indications for Surgery

Surgery is indicated when cataract causes functional visual impairment affecting quality of life. [5] NICE guidelines emphasize patient-centered decision-making rather than arbitrary visual acuity thresholds.

Patient-Centered Indications:

Inability to meet DVLA driving standards (6/12 with both eyes, 6/9 minimum in better eye for commercial)
Difficulty with activities of daily living (reading, cooking, shopping, recognizing faces)
Occupational impact
Increased falls risk (especially important for second eye surgery - restores stereopsis)
Patient request after informed discussion

Medical Indications (Irrespective of Symptoms):

Phacolytic glaucoma: Hypermature cataract leaking lens protein → trabecular meshwork obstruction → acute IOP rise
Phacomorphic glaucoma: Intumescent (swollen) lens causing angle-closure
Lens subluxation/dislocation: Trauma, Marfan syndrome, homocystinuria
Need to visualize fundus: For treatment/monitoring of diabetic retinopathy, AMD, retinal vein occlusion

Relative Contraindications:

Severe corneal endothelial dysfunction (high risk of corneal decompensation)
Active uveitis (defer until controlled)
Uncontrolled glaucoma
End-stage retinal disease with no visual potential (LP or worse)
Patient medically unfit for surgery
Unrealistic patient expectations

Pre-Operative Assessment

Medical Optimization:
- Diabetes: Optimize glucose control; consider deferring if HbA1c > 10% (increased infection risk)
- Anticoagulation: Generally continue warfarin/DOACs (cataract surgery low bleeding risk; local anesthesia used)
- α-blockers (tamsulosin): Document history - increases risk of intraoperative floppy iris syndrome (IFIS)
Ocular Biometry:
- Axial length measurement: Optical biometry preferred (IOLMaster, Lenstar)
- Keratometry: Corneal power measurement
- IOL power calculation: Multiple formulas used (Barrett Universal II most accurate across axial lengths)
- Target refraction:
  - Standard: Emmetropia (plano) or slight myopia (-0.25 to -0.50D) for distance vision
  - Monovision: Non-dominant eye targeted for near (-1.50 to -2.00D) - selected patients
  - Premium IOLs: Multifocal, extended depth of focus (EDOF), toric (astigmatism correction)
Informed Consent:
- Expected outcomes: > 95% achieve improved vision
- Complications: PCO, infection (endophthalmitis 1:1000-2000), retinal detachment (1:1000), PCR (2-5%), CMO (1-2%)
- Glasses requirement: Most need reading glasses (unless multifocal IOL)
- Second eye surgery: Timing, risks, benefits of binocular vision

Surgical Technique: Phacoemulsification

Modern cataract surgery is performed via phacoemulsification (ultrasonic lens fragmentation) with foldable IOL implantation. Surgery duration: 15-25 minutes. Success rate: 95-98%.

Step-by-Step Procedure:

Anesthesia:
- Topical (drops only): Most common, minimally invasive
- Intracameral (anesthetic injected into anterior chamber): Supplement to topical
- Sub-Tenon's block: Local anesthetic injection beneath conjunctiva - good akinesia
- Peribulbar/Retrobulbar block: Rarely used (higher risk complications)
- General anesthesia: Children, anxious patients, communication difficulties
Clear Corneal Incision (CCI):
- Temporal approach (most common): 2.2-2.8mm self-sealing incision at limbus
- Avoids superior approach (astigmatism induction) and nasal approach (anatomical constraints)
- Self-sealing architecture: Triplanar, no sutures typically required
Viscoelastic Injection:
- Ophthalmic viscosurgical device (OVD) injected into anterior chamber
- Protects corneal endothelium from ultrasound energy
- Maintains anterior chamber depth and space
Continuous Curvilinear Capsulorhexis (CCC):
- Critical step: Circular tear in anterior lens capsule (5.0-5.5mm diameter)
- Must be continuous and smooth (prevents radial extension → PCR)
- Cystotome or capsulorrhexis forceps used
- Challenging in: Mature white cataracts (poor red reflex), small pupils
Hydrodissection:
- Balanced salt solution (BSS) injected beneath anterior capsule
- Separates lens cortex from capsule, allowing free rotation
- "Fluid wave" confirms successful hydrodissection
Nuclear Fragmentation (Phacoemulsification):
- Technique options:
  - Divide-and-conquer: Sculpt grooves, crack nucleus into quadrants
  - Chopping techniques: Phaco-chop (horizontal), vertical chop
- Ultrasound probe emulsifies nuclear fragments
- Aspiration removes emulsified material
- Technique selection based on nuclear hardness grade
Irrigation/Aspiration (I/A):
- Bimanual I/A handpiece removes soft cortical material
- "Polish" capsule to remove lens epithelial cells (reduces PCO risk)
IOL Implantation:
- Foldable acrylic IOL injected through 2.4-2.8mm incision
- Unfolds inside capsular bag
- Haptics (arms) secure lens in bag
- IOL types:
  - Monofocal: Single distance focus (standard NHS)
  - Multifocal/EDOF: Multiple foci for spectacle independence (private; increased dysphotopsia risk)
  - Toric: Corrects astigmatism
Viscoelastic Removal:
- Aspirate OVD to prevent post-operative IOP spike
Wound Hydration:
- Stromal hydration seals clear corneal incision
- Check wound integrity (Seidel test)
- Sutures only if wound leak
Intracameral Antibiotic:
- Cefuroxime 1mg or moxifloxacin injected into anterior chamber
- Reduces endophthalmitis risk by 5-fold [18]

Post-Operative Care

Immediate Post-Op (Day 1):

Visual acuity check
Slit-lamp examination: Wound integrity, anterior chamber reaction, IOL position
Intraocular pressure measurement
Exclude: Endophthalmitis, wound leak, significant anterior chamber reaction

Early Post-Op (Week 1-4):

Topical Medications:
- Steroid drops (dexamethasone 0.1% or prednisolone acetate 1%) QDS × 2-4 weeks, then taper
- Antibiotic drops (chloramphenicol or moxifloxacin) QDS × 1 week
Precautions:
- Avoid eye rubbing, swimming, heavy lifting for 2 weeks
- Protective eyewear at night (prevent inadvertent trauma)
Review: Week 1-2 post-op

Late Post-Op (Week 4-6):

Final refraction for spectacle prescription
Assess for complications: PCO, CMO, refractive surprise
Discharge if uncomplicated

6. Complications of Cataract Surgery

Despite high success rates, complications occur in ~5-10% of cases. [9] Awareness and early recognition critical for optimal outcomes.

Intra-Operative Complications

1. Posterior Capsule Rupture (PCR)

Incidence: 2-5% (higher in trainees, complex cases)
Mechanism: Excessive posterior pressure during phacoemulsification, weak/thin capsule
Risk Factors: High myopia, pseudoexfoliation, small pupils, hard cataracts, surgical inexperience
Consequences:
- Vitreous prolapse into anterior chamber
- Increased risk: Retained lens fragments, cystoid macular edema (CMO), retinal detachment, endophthalmitis
Management:
- Anterior vitrectomy (remove prolapsed vitreous)
- IOL placement: In capsular bag (if sufficient support), sulcus, or anterior chamber
- Post-op topical NSAIDs to reduce CMO risk

2. Dropped Nucleus/Lens Fragments

Definition: Nuclear fragments fall into vitreous cavity through PCR
Incidence: 0.3-1.6% [19]
Management:
- Do not pursue into vitreous (causes retinal damage)
- Abort cataract surgery, complete anterior vitrectomy
- Refer vitreoretinal surgeon for pars plana vitrectomy (PPV) within 1-2 weeks
- Retained fragments cause: Chronic inflammation, CMO, retinal detachment, glaucoma

3. Suprachoroidal Hemorrhage

Incidence: less than 0.2% (rare but devastating)
Mechanism: Rupture of posterior ciliary artery → choroidal hemorrhage → expulsive hemorrhage
Risk Factors: High myopia, elderly, hypertension, anticoagulation, glaucoma
Presentation: Sudden pain, loss of red reflex, iris prolapse, shallowing of anterior chamber
Management:
- Immediate wound closure
- Abort surgery
- Emergency posterior sclerotomies if expulsive
- Drainage 7-14 days later
Prognosis: Poor (30-50% achieve less than 6/60 vision)

4. Intraoperative Floppy Iris Syndrome (IFIS)

Association: α-1 adrenergic antagonists (tamsulosin for BPH)
Features: Iris billowing, progressive miosis, iris prolapse through wounds
Management:
- Intracameral epinephrine (dilates pupil)
- Iris hooks or Malyugin ring (mechanical pupil expansion)
- Low flow phacoemulsification settings

Early Post-Operative Complications (less than 1 Week)

1. Acute Endophthalmitis

Definition: Intraocular infection (bacterial/fungal)
Incidence: 1:1000-2000 (0.05-0.1%) [10,11,18]
Timing:
- Acute (2-7 days): Gram-positive bacteria (Staph epidermidis 70%, Staph aureus, Streptococci)
- Delayed (weeks-months): Cutibacterium acnes (indolent, granulomatous) [20]
Presentation:
- Pain (hallmark - distinguishes from routine inflammation)
- Decreased vision
- Red eye, chemosis
- Hypopyon (white layered pus in anterior chamber)
- Vitritis (loss of fundal red reflex)
Diagnosis: Clinical; vitreous/aqueous tap for culture
Management (URGENT - hours matter):
- Intravitreal antibiotics: Vancomycin 1mg + Ceftazidime 2.25mg
- Vitreous tap for culture (before antibiotics)
- Consider PPV if severe (VA less than LP, dense vitritis)
- Topical fortified antibiotics
- Systemic antibiotics (controversial - poor intraocular penetration)
Prognosis:
- Good if treated early: 50-60% achieve ≥6/12 vision
- Delayed treatment: Permanent severe vision loss
Prevention: [18]
- Intracameral cefuroxime at end of surgery (5-fold reduction in endophthalmitis) [18]
- Povidone-iodine preparation (5% conjunctival sac, 10% skin)
- Sterile technique

2. Toxic Anterior Segment Syndrome (TASS)

Definition: Sterile inflammation from contaminated irrigating solutions, instruments, IOLs
Timing: Within 12-48 hours (earlier than infectious endophthalmitis)
Presentation: Diffuse limbus-to-limbus corneal edema, fibrinous anterior chamber reaction, NO pain
Distinguishing from Endophthalmitis:
- Earlier onset
- Less pain
- Corneal edema prominent
- No vitritis
Management: Intensive topical steroids (hourly)

3. Corneal Edema

Causes:
- Endothelial damage from phaco energy
- Prolonged surgery
- Pre-existing Fuchs dystrophy
Presentation: Blurred vision, stromal thickening, epithelial microcystic edema
Management:
- Hypertonic saline drops (NaCl 5%)
- Topical steroids
- Resolves over days-weeks if mild
- Persistent edema → bullous keratopathy → corneal transplant

4. Raised Intraocular Pressure

Causes:
- Retained viscoelastic (most common)
- Retained lens material
- Steroid response
- Pre-existing glaucoma
Timing: Day 1 post-op
Management:
- Topical IOP-lowering agents (timolol, dorzolamide, brimonidine)
- Oral acetazolamide if severe (> 30 mmHg)
- Usually resolves within 24-72 hours

Late Post-Operative Complications (> 1 Week)

1. Posterior Capsule Opacification (PCO)

Incidence: 10-20% within 2-5 years [9]
Mechanism: Lens epithelial cell proliferation on posterior capsule (Elschnig pearls), fibrosis
Presentation: Gradual vision decline months-years post-surgery ("cataract has come back")
Risk Factors: Young age, diabetes, uveitis, capsular bag instability
Prevention:
- Sharp-edge IOL optics (square edge design creates barrier)
- Thorough cortical cleanup and capsule polishing
Treatment: Nd:YAG Laser Capsulotomy
- Outpatient laser procedure (2-5 minutes)
- Create central opening in posterior capsule (3-4mm)
- Immediate visual improvement
- Complications: IOP spike (30% transient), retinal detachment (0.5-2%), CMO (rare)

2. Cystoid Macular Edema (Irvine-Gass Syndrome)

Incidence: 1-2% (clinical CMO); 20-30% (subclinical on OCT)
Timing: 4-12 weeks post-op
Mechanism: Inflammatory prostaglandin-mediated breakdown of blood-retinal barrier → macular edema
Risk Factors: Diabetic retinopathy, epiretinal membrane, uveitis, PCR, vitreous loss
Presentation: Painless reduction in vision (6/12-6/18 range)
Diagnosis: OCT shows cystoid macular thickening
Management:
- Topical NSAIDs (ketorolac, nepafenac) QDS × 3-6 months
- Topical steroids
- Sub-Tenon's steroid injection (triamcinolone)
- Intravitreal steroid if refractory (dexamethasone implant)
Prognosis: Most resolve within 3-6 months; 5% chronic

3. Retinal Detachment

Incidence: 0.5-1.0% (3-10× general population risk)
Mechanism: Vitreous traction on retina (posterior vitreous detachment induced by surgery)
Risk Factors: High myopia (>-6D), PCR, young age, lattice degeneration
Timing: Weeks to years post-op (highest risk first 6 months)
Presentation: Flashes, floaters, visual field defect (shadow/curtain)
Management: Urgent vitreoretinal referral for surgical repair (PPV, scleral buckle)

4. Refractive Surprise

Definition: Post-operative refraction significantly different from target
Causes:
- Biometry measurement error
- IOL power calculation error
- Wrong IOL implanted
- Anterior capsule phimosis (contracture) shifting IOL position
- Axial length measurement error in high myopes
Management:
- Spectacle correction if less than 1.5D
- IOL exchange if early (less than 1 month) and significant error
- Piggyback IOL (second IOL in sulcus)
- Refractive surgery (LASIK, PRK) if stable refraction

5. Capsular Phimosis/Contraction

Mechanism: Myofibroblastic contraction of anterior capsule opening
Risk Factors: Pseudoexfoliation, diabetes, retinitis pigmentosa, uveitis
Consequences:
- IOL decentration (astigmatism, visual aberrations)
- Capsular bag-IOL complex movement (dysphotopsia)
Treatment: Nd:YAG laser anterior capsule relaxing incisions

6. Dysphotopsias

Positive Dysphotopsia: Unwanted visual phenomena (glare, halos, arcs, starbursts)
- Common with multifocal IOLs
- Edge reflection from IOL optic
- Usually neuroadaptation over 3-6 months
Negative Dysphotopsia: Dark shadow in temporal field
- Affects 10-15% patients
- Gap between iris and IOL edge
- Usually resolves spontaneously; IOL exchange if persistent

7. Surgical Atlas: Phacoemulsification Step-by-Step

Pre-Operative Preparation

Pupil dilation: Tropicamide 1% + phenylephrine 2.5% (or cyclopentolate 1%)
Topical anesthesia: Oxybuprocaine 0.4% or lidocaine 1%
Antisepsis: Povidone-iodine 5% conjunctival sac, 10% periocular skin
Draping: Sterile adhesive drape, speculum inserted

Surgical Steps

1. Clear Corneal Incisions

Main incision: 2.4-2.8mm temporal clear corneal, triplanar, 2mm anterior to limbus
Side port (paracentesis): 1.0mm, 60-90° from main incision, for second instrument access
Architecture: Self-sealing, valvular, oblique tunnel

2. Viscoelastic Injection

Cohesive OVD (e.g., Healon) into anterior chamber
Deepens AC, protects endothelium, maintains space

3. Continuous Curvilinear Capsulorhexis (CCC)

Initiate: Cystotome creates flap in anterior capsule
Tear: Capsulorrhexis forceps grasp flap, create continuous circular tear
Diameter: 5.0-5.5mm (must overlap IOL optic 360° for stability)
Direction: Centripetal force (tear toward center)
Challenges:
- Mature white cataract (poor red reflex): Trypan blue capsule staining
- Small pupil: Iris hooks or Malyugin ring

4. Hydrodissection

27G cannula beneath anterior capsule at equator
Inject balanced salt solution (BSS) to create fluid wave
Separates cortex from capsule
Verify: Lens rotates freely (360° hydrodissection)

5. Nuclear Fragmentation

Technique: Divide-and-Conquer (Soft-Moderate Nuclei)

Sculpt: Phaco probe creates two deep grooves (cross pattern)
Crack: Second instrument levers nucleus, fracturing into 4 quadrants
Emulsify: Phaco probe emulsifies each quadrant sequentially
Parameters: Ultrasound power 60-80%, vacuum 300-400 mmHg

Technique: Phaco-Chop (Hard Nuclei)

Impale: Phaco probe buries tip in central nucleus
Chop: Chopper brought from periphery, pulled toward phaco tip, creating fracture line
Repeat: Multiple chops create nuclear fragments
Advantages: Less ultrasound energy (endothelial protection), faster for hard nuclei

6. Irrigation/Aspiration (I/A)

Bimanual I/A handpiece (aspiration port + irrigation port)
Remove soft cortex from capsular bag
Technique:
- "Cortical cleanup" in clockwise fashion
- Engage peripheral cortex, strip centrally
- Subincisional cortex: Rotate eye or use irrigation to dislodge
Polish capsule: Aspirate lens epithelial cells (reduces PCO)

7. IOL Implantation

Viscoelastic re-fill: Inflate capsular bag
IOL loading: Foldable acrylic lens loaded into injector cartridge
Injection: Insert injector tip through main incision, advance into capsular bag
Deploy: Inject IOL; trailing haptic unfolds first, then leading haptic
Position: Ensure IOL centered, both haptics in capsular bag (not sulcus)
Rotate: If toric IOL, rotate to align axis marks

8. Viscoelastic Removal

I/A handpiece aspirates OVD from anterior chamber and behind IOL
Critical: Retained viscoelastic → post-op IOP spike
"Rock and roll" IOL to mobilize OVD behind optic

9. Intracameral Antibiotic

Cefuroxime 1mg in 0.1mL or moxifloxacin 0.15mg
Inject into anterior chamber via side port
Evidence: 5-fold reduction in endophthalmitis [18]

10. Wound Closure

Stromal hydration: BSS injected into stromal lamellae flanking incision → swells → seals wound
Seidel test: Fluorescein strip to check wound leak
Suture only if wound gapes (10-0 nylon)

11. Post-Operative Drop

Topical steroid-antibiotic combination (dexamethasone + neomycin or chloramphenicol)

8. Technical Appendix: IOL Biometry and Power Calculation

Biometry Measurements

Axial Length (AL):

Distance from corneal vertex to retinal pigment epithelium (RPE)
Normal: 23-24mm
Optical biometry (IOLMaster, Lenstar):
- Partial coherence interferometry (PCI) or swept-source OCT
- Accuracy: ±0.01-0.02mm
- Non-contact, rapid, patient-friendly
- Fails in dense cataracts → use A-scan ultrasound
A-scan ultrasonography:
- Contact or immersion technique
- Accuracy: ±0.1mm (10× less precise than optical)
- Operator-dependent

Keratometry (K):

Corneal curvature measurement (anterior surface)
Expressed as radius (mm) or diopters (D)
Normal: 42-44D (7.5-8.0mm radius)
Techniques:
- Automated keratometry
- Corneal topography/tomography (more comprehensive)
- Optical biometry integrated K

Anterior Chamber Depth (ACD):

Distance from cornea to anterior lens surface
Important for IOL power calculations (newer formulas)
Normal: 3.0-3.5mm

Lens Thickness (LT):

Measured by optical biometry
Increases with age (~0.02mm/year)

IOL Power Calculation Formulas

Goal: Calculate IOL power to achieve target refraction (usually emmetropia or slight myopia).

Formula Evolution:

1st Generation (SRK): Theoretical, regression-based
2nd Generation (SRK II): Personalized A-constant
3rd Generation (SRK/T, Holladay 1, Hoffer Q, Haigis): Improved accuracy across axial lengths
4th Generation (Barrett Universal II, Olsen, Hill-RBF): Artificial intelligence, thick lens formulas

Modern Formula Selection:

Barrett Universal II: Most accurate across all axial lengths (current gold standard)
Haigis: Excellent for short/long eyes, uses ACD
SRK/T: Reliable for average eyes (22-26mm AL)
Hoffer Q: Best for short eyes (less than 22mm)
Holladay 1: Good for average eyes

Variables:

AL (axial length)
K (keratometry)
ACD (anterior chamber depth) - in modern formulas
A-constant (IOL-specific constant)
Target refraction

Refractive Target Selection:

Emmetropia (Plano to -0.25D):
- Best distance vision
- Requires reading glasses for near work
- Standard for most patients
Mild Myopia (-0.50 to -1.00D):
- Some distance blur (acceptable to some patients)
- Better unaided near vision
- Option for patients who "never wore glasses for reading"
Monovision:
- Dominant eye: Distance target
- Non-dominant eye: Near target (-1.50 to -2.00D)
- Suitable for patients adapted to contact lens monovision
- Caution: Reduces stereopsis; not suitable for drivers who need binocular vision
Mini-Monovision:
- Smaller anisometropia (-0.75 to -1.25D)
- Better tolerance, less stereopsis loss

Premium IOLs:

Multifocal IOLs:
- Concentric zones for distance and near vision
- Spectacle independence for most tasks
- Drawbacks: Glare, halos, reduced contrast sensitivity
- Not suitable for: Drivers, macular pathology, high expectations
Extended Depth of Focus (EDOF):
- Single elongated focus (distance to intermediate)
- Less dysphotopsia than multifocal
- May still need reading glasses for fine print
Toric IOLs:
- Corrects corneal astigmatism ≥1.0D
- Reduces spectacle dependence
- Requires precise alignment (axis marking)

9. Special Populations

Congenital Cataracts

Epidemiology: 1-6 per 10,000 live births. Cause of 10-15% of childhood blindness globally.

Critical Window: First 6-8 weeks of life. Deprivation amblyopia develops if visual axis blocked during critical period of visual development. Irreversible if not treated early.

Red Reflex Screening: MANDATORY in newborn examination (NIPE check). Absent or abnormal red reflex requires urgent ophthalmology referral.

Etiology:

Idiopathic (50%)
Genetic (25%): CRYAA, CRYAB, CRYGC, GJA3, GJA8, MIP mutations
Intrauterine infections (TORCH): Rubella, CMV, Toxoplasmosis, Herpes, Syphilis
Metabolic: Galactosemia (reversible if early diet), galactokinase deficiency
Syndromes: Down, Lowe (oculocerebrorenal), Alport

Morphology Clues:

Lamellar cataract: Genetic (autosomal dominant)
Oil droplet: Galactosemia (medical emergency - lactose-free diet)
Posterior lenticonus: Alport syndrome (hearing loss, renal disease)

Management:

Urgent surgery: Within 4-8 weeks for dense bilateral cataracts (prevent amblyopia)
Technique:
- Lens aspiration (soft infantile lens)
- Anterior vitrectomy + posterior capsulotomy (high PCO rate in children)
Refractive Rehabilitation:
- IOL: Increasingly implanted in children > 2 years (axial length more stable)
- Contact lenses: Preferred less than 2 years (eye still growing; IOL power changes)
- Spectacles: Aphakic glasses (thick, heavy; poor compliance)
Amblyopia Treatment:
- Occlusion therapy (patching better eye)
- Critical even after surgery to develop visual pathways

Prognosis: Depends on:

Age at surgery (earlier = better)
Unilateral vs bilateral (unilateral worse due to amblyopia)
Compliance with glasses/contact lenses and patching

Diabetic Patients

Increased Risk:

Cataracts develop 10-15 years earlier
Posterior subcapsular type predominant
Bilateral and symmetric

Pre-Operative Considerations:

Diabetic retinopathy (DR) assessment:
- Perform dilated fundoscopy or OCT
- Treat severe NPDR/PDR before cataract surgery (panretinal photocoagulation or anti-VEGF)
- Diabetic macular edema: May worsen post-op
Glycemic control:
- Optimize HbA1c (less than 8-9% acceptable; less than 10% preferred)
- Poor control increases endophthalmitis and wound healing complications
Small pupil: Diabetic autonomic neuropathy → poor dilation → increased surgical difficulty

Intra-Operative:

Higher PCR risk (weak zonules, small pupil)
Consider pupil expansion devices

Post-Operative:

Increased CMO risk (2-3× general population)
Prophylactic topical NSAIDs recommended
Accelerated DR progression in 5-10% (controversial - may be unmasking existing disease)
Earlier and more frequent post-op reviews

Pseudoexfoliation Syndrome

Definition: Deposition of abnormal extracellular material (fibrillin) on lens capsule, zonules, iris, trabecular meshwork.

Prevalence: 10-20% of cataract surgery patients (increases with age).

Surgical Challenges:

Zonular weakness:
- High risk of zonular dialysis (10-20%)
- Phacodonesis (lens wobble)
- Intra-operative lens subluxation
- Vitreous loss
Small pupil: Poor dilation (ischemic iris)
Capsular fragility: Increased risk of capsular tears (anterior and posterior)
Glaucoma: 30-40% have or develop glaucoma (trabecular meshwork clogged)

Management:

Pre-operative: Capsular tension ring (CTR) if zonular weakness
Gentle hydrodissection (avoid zonular stress)
Lower phaco parameters
Consider CTR or capsular hooks if intra-operative instability
Post-op: Monitor IOP (higher risk glaucoma)

High Myopes (Axial Length > 26mm)

Surgical Risks:

Posterior capsule rupture (thin, fragile capsule)
Retinal detachment (3-5× increased risk; pre-existing vitreoretinal degeneration)
Suprachoroidal hemorrhage (thin sclera, large choroidal vessels)

Biometry Challenges:

Difficult accurate AL measurement (posterior staphyloma)
IOL calculation errors (formulas less accurate at extremes)
Use Barrett Universal II or Haigis formula

Refractive Target:

Consider mild residual myopia (-0.50 to -1.50D) - myopes accustomed to near vision
Emmetropia can be psychologically difficult ("everything too far away")

10. Evidence and Guidelines

NICE Guideline NG77: Cataracts in Adults (2017) [5]

Key Recommendations:

Patient-Centered Decision Making:
- Do NOT restrict cataract surgery based solely on visual acuity thresholds
- Surgery indicated when cataract causes functional impairment affecting quality of life
- Consider: Daily activities, driving, reading, work, hobbies, safety (falls risk)
Prioritization:
- First eye surgery: Based on symptoms and functional impact
- Second eye surgery: Should be prioritized (restores binocular vision, depth perception, reduces falls)
- Do not apply arbitrary time delays between eyes
Pre-Operative Assessment:
- Biometry for all patients (IOL power calculation)
- Assess ocular comorbidities (AMD, glaucoma, diabetic retinopathy)
- Manage patient expectations (residual refractive error, need for glasses)
Informed Consent:
- Discuss: Expected outcomes, risks (endophthalmitis, PCR, RD), glasses requirement
- Premium IOLs: Explain limitations (dysphotopsia, not suitable for all)
Post-Operative Care:
- Provide written information on warning signs (endophthalmitis, RD)
- Arrange follow-up: Day 1, Week 1-2, Week 4-6
Audit Standards:
- PCR rate: less than 2% (benchmark for surgical quality)
- Endophthalmitis rate: less than 0.05%
- ≥85% of patients achieve 6/12 or better vision post-operatively

ESCRS Guidelines on Endophthalmitis Prophylaxis [18]

Evidence-Based Prophylaxis:

Intracameral Cefuroxime 1mg (at end of surgery):
- Level 1 Evidence: ESCRS study (16,603 patients) demonstrated 5-fold reduction in endophthalmitis (0.345% → 0.062%)
- Gold standard prophylaxis
- Superior to topical antibiotics alone
Povidone-Iodine Antisepsis:
- 5% conjunctival sac irrigation (3-5 minutes contact time)
- 10% periocular skin preparation
- Reduces conjunctival bacterial load by 90%
NOT Recommended:
- Pre-operative topical antibiotics (no proven benefit, increases antibiotic resistance)
- Post-operative subconjunctival antibiotic injections (painful, no added benefit with intracameral)

Royal College of Ophthalmologists (RCOphth) Cataract Surgery Guidelines

Quality Standards:

Refractive Outcomes:
- ≥85% within ±1.0D of target refraction
- ≥55% within ±0.5D of target
Visual Outcomes:
- ≥90% achieve 6/12 or better (if no ocular comorbidity)
Complication Rates:
- PCR: less than 2%
- Endophthalmitis: less than 0.05%
- Retinal detachment: less than 1%

American Academy of Ophthalmology (AAO) Preferred Practice Pattern

Indications for Surgery:

Visual symptoms affecting quality of life
BCVA does NOT determine surgical need alone
Medical indications: Lens-induced glaucoma, need for fundus visualization

Surgical Technique:

Phacoemulsification preferred over extracapsular cataract extraction (ECCE) unless contraindicated
Posterior chamber IOL standard of care

Post-Operative Medications:

Topical steroids: Minimum 2 weeks (extend if inflammation)
Topical antibiotics: 1 week (or intracameral alternative)
Topical NSAIDs: Consider for high CMO risk (diabetics, uveitis history)

11. Patient/Layperson Explanation

What is a Cataract?

Inside your eye, there is a natural lens (like a camera lens) that focuses light onto the retina at the back of your eye. When you are born, this lens is completely clear, like a clean window. As you get older, the lens gradually becomes cloudy or "frosted," like looking through a steamed-up bathroom mirror. This clouding is called a cataract.

Cataracts are a normal part of aging - most people over 80 have them. They are NOT a growth or film over the eye. The cloudiness is inside the lens itself.

What are the Symptoms?

Blurry vision that gets slowly worse over months or years
Difficulty seeing at night, especially driving with oncoming headlights causing glare
Colors look faded or yellowish
Needing brighter lights to read
Trouble reading small print even with reading glasses
Double vision in one eye (seeing two images)

Cataracts do NOT cause pain, redness, or sudden vision loss. If you have those symptoms, it's something else and you should see a doctor urgently.

Can Cataracts be Prevented or Cured with Drops?

No. There are no eye drops, tablets, or lifestyle changes that can reverse cataracts. Beware of misleading advertisements for "cataract reversal" products - they do not work.

However, you can slow down cataract development by:

Wearing UV-protective sunglasses in bright sunlight
Not smoking
Controlling diabetes if you have it

How are Cataracts Treated?

The only treatment for cataracts is surgery. Fortunately, cataract surgery is:

Very safe and effective (95-98% success rate)
The most common operation in the UK (over 450,000 per year)
Quick (15-20 minutes)

You don't have to have surgery if your vision is still good enough for your daily life. Surgery is only needed when the cataract bothers you - for example, if you can't drive safely, can't read, or can't do your hobbies.

What Happens During Surgery?

Modern cataract surgery is called phacoemulsification ("phaco" for short):

Anesthesia: You are awake during surgery, but the eye is completely numb with anesthetic drops. You won't feel any pain. Some people prefer a small injection to numb the area around the eye.
Tiny Incision: The surgeon makes a 2-3mm incision at the edge of your cornea (clear front part of your eye). This is so small it usually doesn't need stitches.
Ultrasound Probe: The surgeon inserts a tiny ultrasound probe that breaks up the cloudy lens into tiny pieces, which are sucked out.
Artificial Lens: A clear plastic lens (called an intraocular lens or IOL) is inserted to replace your natural cloudy lens. This lens is permanent and invisible from the outside.
No Stitches: The incision is self-sealing in most cases.

Is Laser Used?

Not usually. Despite common belief, cataracts are NOT removed by laser. The ultrasound probe ("phaco") does the work.

Lasers are sometimes used years after cataract surgery if the thin membrane behind the artificial lens becomes cloudy (called "posterior capsule opacification"). A quick laser treatment (YAG capsulotomy) can fix this in 2 minutes.

Will I be Asleep?

Usually no. Most cataract surgery is done with local anesthetic drops or a small injection while you are awake. You won't see the surgery clearly (the bright microscope light prevents detailed vision), and you won't feel pain.

Some people prefer or need general anesthetic (fully asleep), especially if:

You are very anxious
You have difficulty lying still (e.g., tremor, back pain)
You are deaf or have communication difficulties
You are a child

How Long is Recovery?

Vision: Most people notice improved vision within 24-48 hours, though it continues to improve over 4-6 weeks.
Activities: You can watch TV, read, and do light activities immediately. Avoid:
- Rubbing your eye (2 weeks)
- Swimming (2 weeks)
- Heavy lifting (2 weeks)
- Strenuous exercise (1 week)
Eye Drops: You'll need antibiotic and steroid drops for 2-4 weeks.
Driving: You can drive once you meet DVLA standards (usually 1-2 weeks). Check with your doctor.

Will I Still Need Glasses?

Most people still need glasses after cataract surgery, but often only for reading or distance (not both).

The artificial lens can be set to give you:

Good distance vision (TV, driving) - you'll need reading glasses
Good near vision (reading) - you'll need distance glasses for driving (uncommon choice)
"Monovision" - one eye for distance, one for near (some people adapt well, others don't)

Premium "multifocal" lenses claim to give good distance AND near vision without glasses, but they:

Cost extra (not covered by NHS)
Can cause glare and halos around lights
Don't work for everyone

What are the Risks?

Cataract surgery is very safe, but like all surgery, there are risks:

Common (Easily Treatable):

Cloudy capsule (10-20%): The membrane behind the artificial lens becomes cloudy months or years later. Easily fixed with a 2-minute laser treatment (YAG capsulotomy).
Mild inflammation (common): Treated with eye drops.

Uncommon (More Serious):

Infection (endophthalmitis): 1 in 1,000-2,000. Serious but treatable if caught early. Warning sign: Worsening pain and vision 2-5 days after surgery - seek urgent medical attention.
Retinal detachment: 1 in 1,000. Symptoms: Sudden flashes, floaters, shadow/curtain in vision. Requires urgent treatment.
Bleeding inside the eye: Very rare (less than 1 in 1,000).

Overall, 95-98% of people have successful surgery with improved vision.

When Should I Seek Urgent Help After Surgery?

Contact your eye unit immediately if you experience:

Increasing pain (especially 2-7 days after surgery)
Worsening vision after initial improvement
Flashes of light or new floaters
Shadow or curtain across your vision

These could be signs of infection or retinal detachment and need urgent treatment.

12. Viva/Exam Scenarios

Scenario 1: Pre-Operative Assessment

Examiner: "An 82-year-old woman presents with bilateral cataracts. Her VA is 6/18 in the right eye and 6/12 in the left. She lives independently but has stopped driving. What factors determine whether she needs surgery?"

Model Answer: "Cataract surgery is indicated when the cataract causes functional visual impairment affecting quality of life, not solely based on visual acuity thresholds. [5] NICE NG77 emphasizes patient-centered decision-making.

In this case, key factors include:

Driving: She has stopped driving - likely due to visual impairment. DVLA requires 6/12 binocular vision. This significantly impacts independence.
Activities of daily living: I would ask about reading, cooking, shopping, hobbies, and whether vision limits these.
Falls risk: Cataracts reduce contrast sensitivity and depth perception, increasing falls risk, especially in elderly patients.
Patient wishes: Does she want surgery? What are her expectations?

I would also assess:

Ocular comorbidities: Diabetic retinopathy, AMD, glaucoma - these limit post-operative visual potential and must be discussed during consent.
Medical fitness: Can she tolerate surgery?
Second eye: Given her age and independence, I would likely recommend sequential bilateral surgery to restore binocular vision and reduce falls risk.

Decision: Based on functional impact (stopped driving) and likely other ADL limitations at 6/18, she is an appropriate surgical candidate pending full assessment and informed consent."

Examiner: "What pre-operative investigations would you arrange?"

Model Answer: "Essential pre-operative investigations include:

Ocular Biometry:
- Measures axial length, keratometry, anterior chamber depth
- IOL power calculation using modern formulas (Barrett Universal II preferred)
- Determine target refraction (usually emmetropia or mild myopia)
Slit-Lamp Examination:
- Grade cataract type and density
- Assess pupil dilation, phacodonesis (zonular weakness), pseudoexfoliation
- Evaluate corneal health (endothelial dystrophy?)
Dilated Fundoscopy or OCT:
- Assess for macular pathology (AMD, diabetic macular edema)
- Check optic nerve (glaucoma)
- Identify retinal pathology limiting visual potential
B-Scan Ultrasound (if fundus view obscured by dense cataract):
- Exclude retinal detachment, vitreous hemorrhage, tumors
Specular Microscopy (if corneal pathology suspected):
- Assess endothelial cell count
- Low count (less than 1000 cells/mm²) relative contraindication
Medical Optimization:
- Diabetic control (HbA1c if diabetic)
- Anticoagulation status (generally continue)
- Drug history: α-blockers (tamsulosin) → IFIS risk"

Scenario 2: Intra-Operative Complication

Examiner: "During phacoemulsification, you notice the posterior capsule has ruptured and vitreous is prolapsing into the anterior chamber. How do you manage this?"

Model Answer: "Posterior capsule rupture (PCR) is a recognized complication occurring in 2-5% of cases. [9] Immediate recognition and systematic management are critical to minimize consequences.

Immediate Steps:

Stop phacoemulsification: Remove phaco probe to prevent further vitreous traction.
Assess extent of rupture: Small peripheral tear vs large central defect.
Protect vitreous: Inject cohesive viscoelastic to tamponade vitreous and deepen AC.

Anterior Vitrectomy: 4. Vitrectomy handpiece: Remove all prolapsed vitreous from AC using automated vitrectomy cutter. 5. Technique: Cut mode (not aspiration alone - causes traction). Work posterior to anterior. 6. Complete removal: Critical to prevent: CMO, retinal detachment, pupil capture.

Nuclear Management: 7. If nucleus still in bag: Gently remove remaining fragments with phaco or I/A. 8. If nucleus dropped into vitreous:

STOP. Do not pursue fragments posteriorly (causes retinal damage).
Complete anterior vitrectomy.
Refer to vitreoretinal surgeon for pars plana vitrectomy within 1-2 weeks. [19]

IOL Placement: 9. Assess capsular support:

Adequate support: Place IOL in capsular bag or sulcus (optic capture technique if needed)
Insufficient support: Anterior chamber IOL or scleral-fixated IOL (secondary procedure)

Adjust IOL power: Sulcus IOL requires -0.5 to -1.0D less power than bag.

Post-Operative: 11. Topical NSAIDs: To reduce CMO risk (ketorolac or nepafenac). 12. Intensive steroids: Control inflammation. 13. Close follow-up: Day 1, Day 3-5, Week 1 (monitor for CMO, RD). 14. Document: Full documentation, inform patient, incident report.

Prognosis: With appropriate management, 80-90% achieve good visual outcomes. Main risks: CMO (5-10%), retinal detachment (1-2%), residual refractive error."

Scenario 3: Post-Operative Complication

Examiner: "A patient calls 4 days after cataract surgery complaining of worsening pain, redness, and reduced vision. What is your differential diagnosis and management?"

Model Answer: "This presentation - pain, redness, reduced vision 4 days post-operatively - raises immediate concern for acute endophthalmitis (intraocular infection), a true ocular emergency. [10,11]

Differential Diagnosis:

Acute Endophthalmitis (MOST LIKELY and MOST SERIOUS):
- Bacterial infection (Staph epidermidis 70%, Staph aureus, Streptococci)
- Timing: 2-7 days post-op
- Key feature: Pain (distinguishes from routine inflammation)
Toxic Anterior Segment Syndrome (TASS):
- Sterile inflammation
- Earlier onset (12-48 hours)
- Less pain, more corneal edema
Severe Uveitis (non-infectious inflammation):
- Usually less acute
- No vitritis
Wound Leak:
- Hypotony, shallow AC
- Positive Seidel test

Immediate Management (URGENT - Same Day Assessment):

Urgent Examination:
- Visual acuity
- Slit-lamp: Hypopyon (layered white cells in AC), corneal edema, fibrin
- Dilated fundoscopy: Vitritis (loss of red reflex, hazy vitreous view) - pathognomonic of endophthalmitis
- IOP measurement
If Endophthalmitis Suspected:
- Vitreous and Aqueous Tap:
  - Aspirate 0.2-0.3mL vitreous (via pars plana) for culture and sensitivity
  - Gram stain + culture (send immediately)
- Immediate Intravitreal Antibiotics (DO NOT wait for culture results):
  - Vancomycin 1mg/0.1mL (Gram-positive cover)
  - Ceftazidime 2.25mg/0.1mL (Gram-negative cover)
- Consider Vitrectomy:
  - If severe (VA less than hand movements, dense vitritis)
  - Vitreous biopsy + therapeutic (remove infected material)
Adjunctive Treatment:
- Topical fortified antibiotics: Vancomycin 5% + ceftazidime 5% hourly
- Topical steroids: Dexamethasone 0.1% hourly (after antibiotic administration)
- Systemic antibiotics: Controversial (poor intraocular penetration); some use moxifloxacin 400mg PO
Close Monitoring:
- Daily review initially
- Repeat intravitreal antibiotics at 48 hours if no improvement

Prognosis: [10]

Early treatment (within 24 hours): 50-60% achieve ≥6/12 vision
Delayed treatment: High risk of severe permanent vision loss (counting fingers or worse)
Outcomes worse with: Virulent organisms (Staph aureus, Streptococci, Gram-negatives)

Key Learning: Endophthalmitis is a diagnosis not to miss. Any patient with pain + reduced vision post-cataract surgery requires same-day assessment and low threshold for intravitreal antibiotics."

13. References

Hashemi H, Pakzad R, Yekta A, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Eye (Lond). 2020;34(8):1357-1370. doi:10.1038/s41433-020-0806-3
GBD 2019 Blindness and Vision Impairment Collaborators. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144-e160. doi:10.1016/S2214-109X(20)30489-7
Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1568):1278-1292. doi:10.1098/rstb.2010.0300
Thiagarajan R, Manikandan R. Antioxidants and cataract. Free Radic Res. 2013;47(5):337-345. doi:10.3109/10715762.2013.777155
National Institute for Health and Care Excellence. Cataracts in adults: management. NICE Guideline NG77. 2017. Available at: https://www.nice.org.uk/guidance/ng77
Royal College of Ophthalmologists. National Ophthalmology Database Audit. 2022.
Lam D, Rao SK, Ratra V, et al. Cataract. Nat Rev Dis Primers. 2015;1:15014. doi:10.1038/nrdp.2015.14
Rice JB, White AG, Scarpati LM, et al. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clin Ther. 2017;39(11):2216-2229. doi:10.1016/j.clinthera.2017.09.011
Linebarger EJ, Hardten DR, Shah GK, Lindstrom RL. Phacoemulsification and modern cataract surgery. Surv Ophthalmol. 1999;44(2):123-147. doi:10.1016/s0039-6257(99)00085-5
Levin HJ, Mehta MS, Storey PP, et al. Endophthalmitis following cataract surgery: visual outcomes, microbial spectrum and complications. Curr Opin Ophthalmol. 2023;34(3):188-194. doi:10.1097/ICU.0000000000000951
Hage A, Bastelica P, Majoulet A, et al. Changes in rates of endophthalmitis after cataract surgery over the last 23 years. J Fr Ophtalmol. 2025;48(2):104385. doi:10.1016/j.jfo.2024.104385
Chan AW, Ho YS, Chung SK, Chung SS. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation. Exp Eye Res. 2008;87(5):454-461. doi:10.1016/j.exer.2008.08.001
Hashim Z, Zarina S. Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes. J Diabetes Complications. 2012;26(4):275-279. doi:10.1016/j.jdiacomp.2012.04.005
Falkowska M, Młynarczyk M, Micun Z, et al. Influence of Diet, Dietary Products and Vitamins on Age-Related Cataract Incidence: A Systematic Review. Nutrients. 2023;15(21):4585. doi:10.3390/nu15214585
Lu B, Christensen IT, Yu T, et al. SUMOylation Evoked by Oxidative Stress Reduced Lens Epithelial Cell Antioxidant Functions by Increasing the Stability and Transcription of TP53INP1 in Age-Related Cataracts. Oxid Med Cell Longev. 2019;2019:7898069. doi:10.1155/2019/7898069
Devgan U. Surgical techniques in phacoemulsification. Curr Opin Ophthalmol. 2007;18(1):19-22.
Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32(3):407-410.
Haripriya A, Baam ZR, Chang DF. Endophthalmitis Prophylaxis for Cataract Surgery. Asia Pac J Ophthalmol (Phila). 2017;6(4):324-329. doi:10.22608/APO.2017200
Waghamare SR, Prasad S, Sankarananthan R, et al. Nucleus drop following phacoemulsification surgery: Incidence, risk factors and clinical outcomes. Int Ophthalmol. 2024;44(1):296. doi:10.1007/s10792-024-03180-z
Mastrogiuseppe E, Alisi L, Romaniello A, et al. Managing Cutibacterium acnes endophthalmitis after cataract surgery: A systematic review and meta-analysis. Surv Ophthalmol. 2025;70(5):788-798. doi:10.1016/j.survophthal.2025.03.012

(End of Enhanced File)

Clinical board

Urgent signals

Exam focus

Linked comparisons

Editorial and exam context